Westpac Banking Corp’s West Pharmaceutical WST Stock Holding History

Westpac Banking Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$162K	Sell	645 -252	-28%	-$62.7K	0.01%	383
2025 Q4	$247K	Buy	897 +177	+25%	+$48.4K	0.02%	336
2025 Q3	$189K	Hold	720	–	–	0.01%	347
2025 Q2	$158K	Hold	720	–	–	0.01%	369
2025 Q1	$161K	Hold	720	–	–	0.01%	354
2024 Q4	$236K	Hold	720	–	–	0.02%	349
2024 Q3	$216K	Hold	720	–	–	0.01%	368
2024 Q2	$237K	Hold	720	–	–	0.02%	314
2024 Q1	$285K	Sell	720 -36	-5%	-$13.3K	0.02%	311
2023 Q4	$266K	Buy	+756	New	+$268K	0.02%	312
2023 Q3	–	Sell	-4,100	Closed	-$1.57M	–	554
2023 Q2	$1.57M	Sell	4,100 -8,198	-67%	-$2.93M	0.11%	213
2023 Q1	$4.26M	Hold	12,298	–	–	0.06%	375
2022 Q4	$2.89M	Sell	12,298 -5,500	-31%	-$1.3M	0.04%	432
2022 Q3	$4.38M	Sell	17,798 -2,200	-11%	-$670K	0.07%	356
2022 Q2	$6.05M	Sell	19,998 -5,274	-21%	-$1.72M	0.08%	323
2022 Q1	$10.4M	Sell	25,272 -3,260	-11%	-$1.28M	0.12%	233
2021 Q4	$13.4M	Sell	28,532 -3,850	-12%	-$1.66M	0.14%	181
2021 Q3	$13.7M	Sell	32,382 -4,000	-11%	-$1.69M	0.15%	179
2021 Q2	$13.1M	Sell	36,382 -11,188	-24%	-$3.7M	0.13%	196
2021 Q1	$13.4M	Hold	47,570	–	–	0.15%	181
2020 Q4	$13.5M	Buy	47,570 +5,028	+12%	+$1.41M	0.15%	166
2020 Q3	$11.7M	Hold	42,542	–	–	0.16%	160
2020 Q2	$9.66M	Hold	42,542	–	–	0.14%	180
2020 Q1	$6.48M	Sell	42,542 -2,714	-6%	-$418K	0.11%	238
2019 Q4	$6.8M	Buy	45,256 +4,828	+12%	+$703K	0.09%	321
2019 Q3	$5.73M	Hold	40,428	–	–	0.08%	334
2019 Q2	$5.06M	Sell	40,428 -2,000	-5%	-$236K	0.08%	313
2019 Q1	$4.68M	Hold	42,428	–	–	0.08%	313
2018 Q4	$4.16M	Hold	42,428	–	–	0.07%	357
2018 Q3	$5.24M	Hold	42,428	–	–	0.09%	312
2018 Q2	$4.21M	Hold	42,428	–	–	0.08%	305
2018 Q1	$3.75M	Sell	42,428 -7,162	-14%	-$670K	0.07%	313
2017 Q4	$4.89M	Hold	49,590	–	–	0.11%	265
2017 Q3	$4.77M	Hold	49,590	–	–	0.11%	292
2017 Q2	$4.69M	Hold	49,590	–	–	0.1%	285
2017 Q1	$4.05M	Hold	49,590	–	–	0.03%	454
2016 Q4	$4.09M	Hold	49,590	–	–	0.04%	405
2016 Q3	$3.69M	Hold	49,590	–	–	0.04%	388
2016 Q2	$3.76M	Buy	49,590 +29,000	+141%	+$2.11M	0.04%	422
2016 Q1	$1.43M	Hold	20,590	–	–	0.02%	510
2015 Q4	$1.24M	Buy	+20,590	New	+$1.24M	0.01%	539

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westpac Banking Corp's WST Position: Q1 2026 in Review

Westpac Banking Corp reduced its West Pharmaceutical (WST) stake by 28% in Q1 2026, selling an estimated $62.7K and leaving 645 shares worth $162K. The position accounts for 0.01% of the portfolio, ranked #383.

Westpac Banking Corp first reported a position in WST in Q4 2015 and has held it in 41 quarters since. The position peaked at $13.7M in Q3 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Westpac Banking Corp held 645 shares of West Pharmaceutical worth $162K as of Q1 2026.
Westpac Banking Corp sold 252 West Pharmaceutical shares in Q1 2026, an estimated $62.7K.
West Pharmaceutical made up 0.01% of Westpac Banking Corp's portfolio in Q1 2026, its #383 holding.
Westpac Banking Corp first reported a position in West Pharmaceutical in Q4 2015 and has held it in 41 quarters since.
Westpac Banking Corp's West Pharmaceutical position peaked at $13.7M in Q3 2021.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.